Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The DIDACT Foundation (Data-driven Integrated Design of Anti-Cancer Treatments) is a non-profit research organization based in the Netherlands dedicated to advancing precision oncology. The foundation focuses on the systematic collection and integration of clinical outcomes with high-resolution molecular data, including whole-genome sequencing. By creating a centralized data infrastructure, DIDACT enables researchers and clinicians to identify biomarkers that predict patient response to specific anti-cancer therapies. The organization operates through a collaborative model, partnering with major Dutch hospitals, the Netherlands Cancer Institute, and the Hartwig Medical Foundation. Its primary goal is to optimize the use of expensive oncology drugs by ensuring they are directed toward the patients most likely to benefit. Through its data-driven approach, the DIDACT Foundation bridges the gap between complex genomic research and routine clinical decision-making to improve overall cancer care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIDACT Foundation.